Target intelligence / Profile preview

Prostaglandin E synthase 3 pseudogene 2 (PTGES3P2)

Target: PTGES3P2
Molecular classification: Other (pseudogene)

Overview

Prostaglandin E synthase 3 pseudogene 2 (PTGES3P2) is classified as a pseudogene, meaning it is a non-protein-coding segment of DNA similar in sequence to the functional prostaglandin E synthase 3 (PTGES3) gene, but typically non-functional and not expressed as an active protein product. Pseudogenes do not have known direct biological activity or established roles in disease processes, and they are generally not considered therapeutic targets such as receptors, enzymes, or transporters.

Other names: PTGES3 pseudogene 2prostaglandin E synthase 3 pseudogene 2

Beyond the preview

Go deeper on Prostaglandin E synthase 3 pseudogene 2 (PTGES3P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prostaglandin E synthase 3 pseudogene 2 (PTGES3P2).

Explore the full profile